CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment.
about
CYP2D6 polymorphisms and their influence on risperidone treatmentLack of association of SNPs from the FADS1-FADS2 gene cluster with major depression or suicidal behaviorApplicability of gene expression and systems biology to develop pharmacogenetic predictors; antipsychotic-induced extrapyramidal symptoms as an example.Network analysis of gene expression in mice provides new evidence of involvement of the mTOR pathway in antipsychotic-induced extrapyramidal symptoms.Successful treatment with risperidone increases 5-HT 3A receptor gene expression in patients with paranoid schizophrenia - data from a prospective study.Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes.Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment.Effect of polymorphisms on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteersUsefulness of Pharmacogenetic Analysis in Psychiatric Clinical Practice: A Case Report
P2860
Q28079227-3D737FB2-3806-41F4-BC4A-D475A14A550CQ36609756-27C76389-123D-443E-9CC2-0B48C41DD5E9Q38630075-756526BE-1FBD-4DB4-9FED-5878A91263DFQ38990216-6579FCC0-BB40-40B1-B22D-197DF9F18EF0Q41691255-E8ACAE55-AE9A-4B61-8642-9AE1056A68FCQ48006592-C6F4C659-D372-46E3-8722-93E5921BEB16Q55216457-D507D646-DA10-4F29-A5D2-96251064D1B0Q57212204-6939A099-4DFF-4F34-8ADD-C40CEFC441D2Q58781437-D72CCBC0-3A02-4FAF-9720-69CED29DF293
P2860
CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
CYP2D6 poor metabolizer status ...... onse to risperidone treatment.
@en
CYP2D6 poor metabolizer status ...... onse to risperidone treatment.
@nl
type
label
CYP2D6 poor metabolizer status ...... onse to risperidone treatment.
@en
CYP2D6 poor metabolizer status ...... onse to risperidone treatment.
@nl
prefLabel
CYP2D6 poor metabolizer status ...... onse to risperidone treatment.
@en
CYP2D6 poor metabolizer status ...... onse to risperidone treatment.
@nl
P2093
P50
P1476
CYP2D6 poor metabolizer status ...... onse to risperidone treatment.
@en
P2093
Berta Almoguera
Concepción Vaquero-Lorenzo
José Fernandez-Piqueras
Rosa Riveiro-Alvarez
Spanish Consortium of Pharmacogenetics Research in Schizophrenia
P304
P356
10.1097/FPC.0B013E3283659A94
P50
P577
2013-11-01T00:00:00Z